Effects of boric acid and borax on titanium dioxide genotoxicity.
Titanium dioxide (TiO(2)) is a potential carcinogenic/mutagenic agent although it is used in many areas including medical industries and cosmetics. Boron (as boric acid and borax) has also well-described biological effects and therapeutic benefits. In a previous study, sister-chromatid exchanges (SCEs) and micronuclei (MN) rates were assessed in control and TiO(2)-treated (1, 2, 3, 5, 7.5 and 10 microm) human whole blood cultures. The results showed that the rates of SCE (at 2, 3, 5, 7.5 and 10 microm) and MN (at 5, 7.5 and 10 microm) formation in peripheral lymphocytes were increased significantly by TiO(2) compared with the controls. The present study also investigated the genetic effects of boric acid and borax (2.5, 5 and 10 microm) on cultures with and without TiO(2) addition. No significant increase in SCE and MN frequencies were observed at all concentrations of boron compounds. However, TiO(2)-induced SCE and MN could be reduced significantly by the presence of boric acid and borax. In conclusion, this study indicated for the first time that boric acid and borax led to an increased resistance of DNA to damage induced by TiO(2).
Turkez
Hasan
H
Department of Biology, Faculty of Arts and Sciences, Atatürk University, 25240, Erzurum, Turkey. hasanturkez@yahoo.com
D000328:Adult; D016587:Antimutagenic Agents; D001881:Borates / Q000494:pharmacology*; D001888:Boric Acids / Q000494:pharmacology*; D002478:Cells, Cultured; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects / Q000648:ultrastructure; D015162:Micronucleus Tests; D009153:Mutagens / Q000633:toxicity*; D012854:Sister Chromatid Exchange / Q000187:drug effects; D014025:Titanium / Q000037:antagonists & inhibitors* / Q000633:toxicity*
D016587:Antimutagenic Agents; D001881:Borates; D001888:Boric Acids; D009153:Mutagens; C018851:borax; C009495:titanium dioxide; D014025:Titanium; C032688:boric acid